Natco got the license because our campaign proved Bayer wasn't making Nexavar accessible enough here—the patent system *does* have a public safety override, yaar. But it hasn't happened much since because the legal fight drained us, and big pharma's pressure just increased tenfold. My own father needed that drug; we saw the price drop like a stone after the ruling, which is why I keep at this work. But now, getting that same urgency for other medicines feels like pushing a rock uphill, bro—every meeting is about "innovation," never about my neighbours who are rationing pills.
#athletics#track-and-field
Jump in to reply — no account needed.